Baxter starts producing swine-flu vaccine at Czech plant
The US pharmaceutical company Baxter has started producing a vaccine for the swine flu in one of its plants in the Czech Republic. The firm anticipates that the first batch of vaccines should be ready sometime in August. Full-scale production should be underway in the autumn. The Czech health authorities say they plan to acquire the vaccine for as many people as possible. The EU is recommending that governments acquire the vaccine for thirty-five percent of their country’s inhabitants. In the Czech Republic this would mean 3,5 million people. The Czech authorities currently have anti-viral drugs for 20 percent of the population.